MML-Medical

What MML-Medical does

MML-Medical B.V. is a Netherlands-based specialty medical device distributor founded in 2011 and headquartered in Ulft, operating through a wholly-owned German subsidiary (MML-Medical GmbH, Belau) and serving hospitals, medical practices, gynecology practices, urology departments, radiology departments, and pharmacy facilities primarily in the Netherlands. The company's portfolio spans four therapeutic areas: urology and interventional oncology (Cryocare Touch cryoablation system, IntelliBlate microwave ablation with myAblation Guide software, radiofrequency ablation for benign thyroid nodules, Embozene embolization microspheres, biopsy instruments, and the Bladder EpiCheck urine biomarker test co-developed with Sanquin Diagnostics); radiology and radiation protection (proprietary BI-LAYER/KIARMOR lead-free aprons, Kenex table and ceiling shields, lead gloves, lead glasses, sterile disposable drapes); gynecology (Etherena TCu380A and Multi-Arm Cu 375 copper IUDs, myoma ablation workshops); and pharmacy/consumer devices (RetMed medication return safes, BiopSafe formaldehyde-free biopsy containers, urine collection bags for contrast-medium disposal, infrared thermometers).

The company monetizes through three core revenue mechanics: (1) capital equipment sales of ablation systems to Dutch hospitals and practices via an enterprise field sales motion offering free trials with expert staff support; (2) branded consumables and disposables (V-Probe cryo needles, BI-LAYER aprons, lead glasses, urine bags, BiopSafe containers) sold through the same channel with recurring pull-through; and (3) a direct-to-consumer e-commerce webshop for radiation protection items, copper IUDs, BiopSafe, thermometers, and urine bags with publicly listed unit pricing. MML-Medical is the Dutch market leader in RFA of benign thyroid nodules and the exclusive Netherlands importer of Kenex radiation protection products, with the option to also supply Mavig alternatives. The company is ISO 9001:2015 certified (since July 2021) and operates an educational events motion including the STARmed Myomablation workshop with Inno-More. As of December 22, 2025, MML-Medical became a wholly-owned subsidiary of Accuramed BV, joining the Accuramed Group to extend coverage across the OR, radiology, and oncology patient journey in the Benelux market.

Name

MML-Medical

Legal name

MML-Medical B.V.

Website

https://mml-medical.nl

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

MML-Medical B.V. is a Netherlands-based specialty medical device distributor founded in 2011, serving Dutch and German hospitals, gynecology, urology, radiology, and pharmacy customers with ablation systems, radiation protection products, biopsy devices, and pharmacy disposables.

Ownership category

akta.pro rank

Product category

Medical Device Distribution - Interventional Medicine

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ)

Keywords

• Medical device distribution
• Interventional radiology devices
• Ablation therapy systems
• Radiation protection products
• Urology medical devices

Headquarters

HQ city

Ulft

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Equipment Sales: Sale of ablation equipment including Cryocare Touch Cryosystem, IntelliBlate Microwave system, and related capital equipment to hospitals and practices.
2. Disposables and Consumables: Sale of disposable medical products including V-Probe cryo needles, radiation protection aprons, gloves, lead glasses, urine bags, biopsy containers, copper IUDs, and other single-use medical devices.
3. Distribution and Import: As Netherlands distributor for Kenex radiation protection products and other brands, MML-Medical generates revenue through distribution margins and import markups.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

MML-Medical B.V. distributes specialized medical devices across urology, radiology, gynecology, radiation protection, and pharmacy to hospitals and medical practices throughout the Netherlands. The company supplies cryoablation, radiofrequency ablation (RFA), and microwave ablation systems, BI-LAYER/KIARMOR radiation protection apparel and shields, the Bladder EpiCheck urine biomarker test, Rayscape AI imaging, BiopSafe biopsy containers, copper IUDs, and pharmaceutical safety devices such as RetMed medication return safes. It also operates a webshop enabling direct online purchase of selected consumables and radiation protection items.

Product overview

MML-Medical is a Dutch medical device distributor and strategic partner offering a diversified portfolio of interventional medical devices across four therapeutic areas: urology (cryoablation, RFA, microwave ablation, Bladder EpiCheck), radiology (ablation technologies, Rayscape AI imaging), gynecology (copper IUDs, myoma ablation), and radiation protection (lead aprons, shields, glasses, gloves). The company also serves the pharmacy sector with medication return safes and biopsy safety products. The core ablation portfolio includes Cryocare Touch for cryoablation, IntelliBlate for microwave ablation, and RFA for thyroid nodules, forming a comprehensive minimally invasive treatment platform. Radiation protection products feature the BI-LAYER/KIARMOR lead-free technology across aprons, shields, and scatter armor. Supporting products include biopsy instruments, urine bags for contrast disposal, positioning cushions, and embolization beads. MML-Medical operates as a webshop-enabled distributor with ISO 9001:2015 certification and became part of the Accuramed Group in December 2025.

Differentiator

Problem solved

Functional benefit

Products and services

• Cryocare Touch Cryosystem

Quantifiable outcome

• Bladder EpiCheck has negative predictive value >99% for high-grade bladder cancer, can reduce cystoscopies by 80% without missing high-grade cancer
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature8 records

Partnerships

One partnership is on record.

• Accuramed BVcoreStrategic or Co-development Partner · 22 December 2025MML-Medical officially became part of the Accuramed Group as of December 22, 2025. This acquisition strengthens their position in interventional medicine, offering customers and partners a broader range of expertise and solutions within the OR, radiology, and oncology. Together they now cover the complete patient journey from diagnosis to treatment.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• AngioDynamics: US-listed medical device company specializing in interventional oncology and vascular access, including ablation technologies and related disposables. Direct overlap with MML-Medical's ablation and interventional radiology portfolio, though at significantly larger scale and broader geographic reach.
• HealthTronics: US-based provider of interventional urology services and equipment, including cryoablation for prostate and kidney cancer. Highly comparable to MML-Medical's urology-focused cryoablation business model and customer base.
• Mavig: German manufacturer of radiation protection products including lead aprons, shields, and related accessories for interventional radiology. Directly comparable to MML-Medical's radiation protection product line (MML is even an authorized Mavig distributor in the Netherlands).
• IceCure Medical: Israel-based cryoablation-focused medical device company developing minimally invasive cryoablation systems for tumors and other indications. Direct peer to MML-Medical's cryoablation franchise (Cryocare Touch), competing in overlapping cryoablation clinical use cases.
• Profound Medical: Canada-based medical device company commercializing the TULSA-PRO system for MRI-guided transurethral ablation of prostate tissue. Direct competitor in the urology/ablation category that overlaps with MML-Medical's prostate and kidney tumor treatment focus.
• EDAP TMS: France-based medical device company developing high-intensity focused ultrasound (HIFU) and other ablation technologies for urology and oncology. Comparable specialty ablation focus and European footprint, competing against MML-Medical's RFA and microwave ablation offerings.

Broad incumbents

• Medtronic: Global medical device leader with a large interventional oncology, ablation, and surgical portfolio including Emprint, Evident, and other ablation systems. Broad incumbent across the categories MML-Medical serves, particularly in European hospitals where MML competes as a niche specialty distributor.
• Medline Industries: Largest privately held manufacturer and distributor of medical supplies globally, with a comprehensive hospital-focused portfolio. Comparable role as a broad-line medical device distributor, including surgical supplies and consumables that overlap with parts of MML-Medical's offering.
• Boston Scientific: Global medical device company with a substantial interventional oncology and peripheral intervention portfolio (including the legacy BTG interventional medicine business). Competes with MML-Medical in embolization, ablation, and interventional radiology at a much larger scale.
• Henry Schein: Large global distributor of medical, dental, and veterinary supplies with a broad product portfolio across multiple specialties. Comparable business model to MML-Medical as a multi-vertical medical device distributor, though operating at vastly greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mml-medical-bv.

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MML-Medical